A Study of Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid Tumors
Clinical trial NCT01288989 · COMPLETED
Trial details
- NCT number
- NCT01288989
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2014-07-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.